Joshua Schimmer at Piper Jaffray is chiming in on two biotech players, Gilead Sciences, Inc. (NASDAQ:GILD) and GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), in …
In a research report published Wednesday, Mizuho Securities analyst Irina Rivkind Koffler reiterated a Buy rating on shares of Mallinckrodt PLC (NYSE:MNK) with …
FireEye Inc (NASDAQ:FEYE) held a Defense Summit Conference yesterday that has Oppenheimer top analyst Shaul Eyal out with bullish praise for the company, …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is anticipated to announce data from the Phase 2 trial of pimavanserin in Alzheimer’s Disease Psychosis (ADP) come December.
Micron Technology, Inc. (NASDAQ:MU) preannounced fiscal first quarter results for 2017 that hit ahead of the high end of its original guidance range …
Nomura analyst Anthony Diclemente is out with a research report taking a glimpse into pressures on shares of Amazon.com, Inc.
Analysts are offering their two cents on biotech firms Amicus Therapeutics, Inc. (NASDAQ:FOLD) and Synergy Pharmaceuticals Inc (NASDAQ:SGYP).
After Amicus Therapeutics, Inc. (NASDAQ:FOLD) met with the FDA and received written minutes, the biotech firm revealed yesterday that with the present data …
This morning, Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced a licensing and collaboration agreement with Vivelix for rights to develop and market IMO-9200, a TLR …
Anavex Life Sciences Corp. (NASDAQ:AVXL) shares are on a 10% rise after biotech firm Lilly’s drug Solanezumab (“Sola”) just failed its third Phase …
